Abbott Seeks to Terminate Alere Acquisition: 'Not The Company We Agreed To Buy'

By: via Benzinga
Abbott Laboratories (NYSE: ABT) has filed a complaint seeking to terminate its $5.8 billion proposed acquisition of Alere Inc (NYSE: ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.